Cooperative Agreement 1C1CMS331341

Federal Cooperative Agreement Summary: HIPACT3 Kapi'olani Medical Center for Women and Children received a Cooperative Agreement award of $309,121.00 from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 1, 2025, through May 31, 2030. The award funds the Hawaii IDEA Center for Pediatric and Adolescent Clinical Trials (HIPACT3), which strengthens pediatric clinical trial capacity in Hawaii through a...

Federal Cooperative Agreement Summary The National Institute of Child Health and Human Development (NICHD) awarded The Children's Hospital of Philadelphia (CHOP) a $2.63 million Cooperative Agreement on September 24, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish and lead the Pediatric Fungal Network Study of Rare Invasive Fungal Diseases in Immunocompromised Pediatric Patients (PFN-STRIDE) Rare Diseases Clinical Research Consortium (RDCRC). The...

Advancing Craniosynostosis Treatment (ACT) Rare Diseases Consortium The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Children's Hospital of Philadelphia a Cooperative Agreement for $800,000 on August 19, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to establish and operate the Advancing Craniosynostosis Treatment (ACT) Rare Diseases Consortium through May 31, 2030. ACT is a multi-site, patient-centric translational and clinical research...

This Project Grant award from the National Center for Advancing Translational Sciences (CFDA 93.350) provides $159,103 to investigate the experiences of parents seeking emergency care for their injured children with special healthcare needs. The study will engage at least 35 family caregivers to gather qualitative data on factors contributing to poor care quality and hospital complications for this population. The project aims to elucidate the mechanisms behind adverse outcomes in injured...

Federal Project Grant Award Summary Connecticut Children's Medical Center received a $156,340 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2025, with completion targeted by May 31, 2030. This Mentored Patient-Oriented Research Career Development (K23) award supports Dr. Siddika Mulchan's five-year research program investigating provider-focused interventions to improve health outcomes...

Federal Project Grant Award Summary The Children's Hospital of Philadelphia, through its Research Institute Division, received a $2,272,471 Project Grant award dated August 18, 2025, from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award supports the Pediatric Acute Respiratory Distress Syndrome Management (PARMA) trial through April 30, 2030. This research initiative addresses a critical...

Federal Cooperative Agreement Summary Ann & Robert H Lurie Children's Hospital of Chicago received a $499,971 Cooperative Agreement from the National Center for Chronic Disease Prevention and Health Promotion (CDC) under the Diabetes Prevention and Control Programs (CFDA 93.988) for the project titled "Chicago Area Surveillance, Statistics, and Analysis Network for Diabetes, with Representative Ascertainment." The award, dated September 30, 2025, with a completion date of September...

The Children's Hospital Corporation, doing business as Boston Children's Hospital, received a $2,000 Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) to study ATP1A3-related disorders in Brazil. The key goals of this 2-year project are to: Establish a large patient cohort in Brazil to study the genotype-phenotype correlation and natural history of ATP1A3-related disorders, which...

This federal Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program provides $285,658.00 to Emory University to develop shared decision-making tools for improving the treatment of childhood nephrotic syndrome, a leading chronic kidney disease that disproportionately affects racial/ethnic minority and low-income children. The project aims to 1) elicit experiences of providers, parents, and...

Federal Grant Award Summary The Children's Hospital of Philadelphia received a $732,541 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective August 7, 2025, with completion targeted for July 31, 2027. The award supports the PARTNERS (Program to Advance Research and Transdisciplinary Training in the Care of Persons with Down Syndrome) initiative, a comprehensive workforce development program...